We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Declaration of interests
- Increasing incidence and prevalence of ESKD
- Diabetic kidney disease shortens lifespan by 16 years
- Diabetes and CKD are both common in the UK
- Staging of CKD
- Factors that may cause a misleading ACR
- Factors that may cause a misleading eGFR
- We are over diagnosing CKD in DM
- DM CKD: an exemplar of multi-morbidity
- CVD risk is greatest with diabetes + CKD
- Managing complex DM takes time
- Anaemia in DM CKD – it’s complicated!
- Glycaemic control in T1DM: CKD outcome
- ACCORD study
- CKD increases hypoglycaemia risk in DM
- Hypoglycaemia, ischaemia and dysrhythmia
- HbA1c and CKD in the National Diabetes Audit
Topics Covered
- The link between Diabetes Mellitus (DM) and Kidney Disease (CKD)
- The impact of obesity and ageing on DM and CKD
- The impact of DKD on life span
- DKD can affect both glomerular filtration and urine albumin excretion
- DKD is linked with multi morbidity especially CVD
Links
Categories:
Therapeutic Areas:
Talk Citation
Winocour, P. (2020, August 11). Managing hyperglycaemia in people with DM and CKD: establishing chronic co-pathology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 9, 2024, from https://doi.org/10.69645/RCYQ9900.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Peter H. Winocour has received honoraria for delivering educational meetings and/or attending advisory boards for Astra Zeneca, BI, Eli Lilly, MSD, Napp, Sanofi, Novo and Vifor Pharmaceuticals.
Managing hyperglycaemia in people with DM and CKD: establishing chronic co-pathology
Published on August 11, 2020
28 min
A selection of talks on Metabolism & Nutrition
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Peter Winocour.
I'm a diabetes consultant in the United Kingdom.
I'm the Clinical Director for the East and
North Herts Institute of Diabetes and Endocrinology
and I was a founder of
the Association of British Clinical Diabetologists and Renal Association-
a diabetes kidney clinical specialty group.
0:20
These are my declarations of interest for the presentation I'm delivering this morning.
0:28
I'm going to talk, today, really,
about the interlink between diabetes and chronic kidney disease.
This is a fairly recent data set from the United States,
looking at both the incidence and prevalence of end-stage kidney disease in general.
You can see here that, really,
there was a slow increase in the incidence of end-stage kidney disease,
probably till the year 2000,
which has been to a greater or lesser extent,
maintained for the last few years.
But, as the population is surviving longer with this significant morbidity,
you can see that there's been a progressive increase in
the prevalence of end-stage kidney disease in the United States,
and this is paralleled by data from other countries,
including the United Kingdom.
1:12
When it comes to diabetes and end-stage kidney disease,
this slide shows quite clearly that there is a cumulative impact of diabetes,
and in addition to that,
of kidney disease, in terms of lifespan.
You can see that, particularly for women,
the presence of diabetes and kidney disease,
as we'll define shortly,
can shorten the lifespan by over 16 years in women,
if this kidney disease develops early in diabetes.
It's around about 15 years in men.
Hide